An interventional study of MusculoSkeletal Ultrasound and MusculoSkeletal Ultrasound in Rheumatoid Arthritis, Patient Reported Outcomes and Musculoskeletal Ultrasound, sponsored by Clínica de Artritis Temprana. Completed at 1 site in Mexico. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2019-01-30.
Sponsored by Clínica de Artritis Temprana · Not applicable, Interventional, and Other
Evaluate the impact of MusculoSkeletal Ultrasound added to Rheumatoid Arthritis patients classified in remission/low disease activity in terms of Patient Reported Outcomes.
3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.
This study's enrollment of 94 is close to the median of 90 across 2,377 interventional studies indexed under Arthritis.
Browse Arthritis studies →This is the only study on the registry with Clínica de Artritis Temprana as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patient will be assessed with ultrasound (GUS-7 score)
Diagnostic Test: MusculoSkeletal Ultrasound
Patient will be assessed with ultrasound (GUS-7 score)
Diagnostic Test: MusculoSkeletal Ultrasound
Patient will be assess with ultrasound (GUS-7 score) and the results will be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization.
Patient will be assess with ultrasound (GUS-7 score) and the results will not be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization.
Change from Baseline of the Patient Reported Outcome (HAQ)
Minimal Clinically Significant change in HAQ
Time frame: From baseline at 6 months
Change from Baseline of the Patient Reported Outcome (RADAI)
Minimal Clinically Significant change in RADAI
Time frame: from baseline at 6 months
Change from Baseline of the Patient Reported Outcome (SF-36)
Minimal Clinically Significant change in SF-36
Time frame: from baseline at 6 months
Change from Baseline of the Patient Reported Outcome (VAS-Patient)
Minimal Clinically Significant change in VAS-Patient
Time frame: from baseline at 6 months
Ultrasound findings in Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity
Describe ultrasound findings at the moment of inclusion in the study.
Time frame: Baseline
Clinical relapse: Proportion of patients with relapse after the intervention in both groups
Describe the proportion of patients with relapse after the intervention in both groups.
Time frame: baseline and 6 months
Change from Baseline of the Patient Reported Outcome (HAQ)
Minimal Clinically Significant change in HAQ
Time frame: from baseline at 12 months
Change from Baseline of the Patient Reported Outcome (RADAI)
Minimal Clinically Significant change in RADAI
Time frame: from baseline at 12 months
Change from Baseline of the Patient Reported Outcome (SF-36)
Minimal Clinically Significant change in SF-36
Time frame: from baseline at 12 months
Change from Baseline of the Patient Reported Outcome (VAS-Patient)
Minimal Clinically Significant change in VAS-Patient
Time frame: from baseline at 12 months
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.